Skip to main navigation Skip to search Skip to main content

Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production

  • Silvana Obici
  • , Zhaohui Feng
  • , Arduino Arduini
  • , Roberto Conti
  • , Luciano Rossetti
  • Albert Einstein College of Medicine
  • F. Hoffmann-La Roche AG
  • Sigma Tau Pharmaceutical Industries

Research output: Contribution to journalArticlepeer-review

474 Scopus citations

Abstract

The enzyme carnitine palmitoyltransferase-1 (CPT1) regulates long-chain fatty acid (LCFA) entry into mitochondria, where the LCFAs undergo β-oxidation. To investigate the mechanism(s) by which central metabolism of lipids can modulate energy balance, we selectively reduced lipid oxidation in the hypothalamus. We decreased the activity of CPT1 by administering to rats a ribozyme-containing plasmid designed specifically to decrease the expression of this enzyme or by infusing pharmacological inhibitors of its activity into the third cerebral ventricle. Either genetic or biochemical inhibition of hypothalamic CPT1 activity was sufficient to substantially diminish food intake and endogenous glucose production. These results indicated that changes in the rate of lipid oxidation in selective hypothalamic neurons signaled nutrient availability to the hypothalamus, which in turn modulated the exogenous and endogenous inputs of nutrients into the circulation.

Original languageEnglish
Pages (from-to)756-761
Number of pages6
JournalNature Medicine
Volume9
Issue number6
DOIs
StatePublished - Jun 1 2003

Fingerprint

Dive into the research topics of 'Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production'. Together they form a unique fingerprint.

Cite this